Axogen Inc. (AXGN) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Axogen Inc. (AXGN:NASDAQ), powered by AI.

Current Price
$43.00
P/E Ratio
-126.1
Market Cap
2.0B
Sector
Healthcare
What is the Axogen Inc. stock price forecast?

Axogen Inc. is currently trading at $43.00. View real-time AI analysis on Alpha Lenz.

What is Axogen Inc. insider trading activity?

View the latest insider trading data for Axogen Inc. on Alpha Lenz.

What is Axogen Inc.'s P/E ratio?

Axogen Inc.'s P/E ratio is -126.1.

Axogen Inc.

NASDAQ · AXGN
$43.00+0.64(+1.51%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Axogen Inc.'s future dividend policy...
Alpha Chat Insight

Axogen Inc. trades at a P/E of -126.1 (undervalued) with modest ROE of -13.5%. 3Y revenue CAGR of 17.6% highlights clear growth momentum.

Ask for details

Company Overview

Axogen Inc. is a specialty medical device company focused on developing and commercializing innovative solutions for peripheral nerve injuries. The primary purpose of its products is to support nerve repair and improve patient outcomes in surgeries involving nerve damage. Axogen's comprehensive portfolio includes products such as nerve grafts, nerve connectors, and nerve protectors, which are used in reconstructive surgeries across neuro-surgical, orthopedic, and head and neck trauma. The company's impact is notable in the healthcare industry, particularly in the surgical and orthopedic sectors. Its offerings provide surgeons with versatile tools to address nerve damage in a manner that can potentially improve patient recovery times and quality of life. Headquartered in Alachua, Florida, Axogen Inc. plays a critical role in the advancement of nerve repair technologies, aiming to address unmet needs in the medical community. With ongoing research and development efforts, the company impacts the market by driving innovations that may redefine standards in nerve repair procedures.

CEOMr. Michael D. Dale
SectorHealthcare
IndustryMedical Devices
Employees451

Company Statistics

FY 2025

Profile

$1.98BMarket Cap
$225.21MRevenue
0.00Shares Out
451Employees

Margins

74.31%Gross
0.37%EBITDA
-3.49%Operating
-6.97%Pre-Tax
-6.97%Net

Valuation

-126.10P/E
15.37P/B
8.79EV/Sales
2436.13EV/EBITDA
-414.09P/FCF

Growth (CAGR)

17.57%Rev 3Yr
14.93%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-7.38%ROA
-13.49%ROE
-3.76%ROIC

Financial Health

$35.55MCash & Cash Equivalents
$57.29MNet Debt
72.05%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Axogen Inc. (ticker: AXGN) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 451 employees. Market cap is $2.0B.

The current price is $43 with a P/E ratio of -126.1x and P/B of 15.37x.

ROE is -13.49% and operating margin is -3.49%. Annual revenue is $225M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Axogen Inc. (AXGN) Stock Forecast 2026 $43.00 — Price, Financials & Analyst Targets | Alpha Lenz